Product/Composition:- | Glimepiride Tablets |
---|---|
Strength:- | 1 mg, 2 mg, 3 mg, 4 mg |
Form:- | Tablets |
Reference Brands:- | Amaryl (US), Amarel(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Glimepiride is a sulfonylurea that lowers blood glucose by stimulating pancreatic β-cells to release insulin. It also enhances peripheral insulin sensitivity and reduces hepatic glucose output. Its once-daily dosing improves patient compliance. Glimepiride is effective in managing type 2 diabetes and can be combined with other antidiabetic agents for better glycemic control.
Glimepiride tablets are FDA-approved in the USA and widely marketed under the brand name Amaryl. Available as generics, they are indicated for type 2 diabetes mellitus. In the EU, Glimepiride is authorized through national and decentralized procedures with brands like Amarel and Glimepirid-1A Pharma. It complies with EMA safety, efficacy, and pharmacovigilance standards. Manufacturers must meet GMP guidelines for EU/US distribution. Glimepiride is included in major formularies and supported by post-marketing surveillance. For pharma companies and global buyers, Pharmatradz.com facilitates sourcing Glimepiride from audited suppliers across regulated markets.